Temozolomide and its stability—a critical factor

Zenab Attari, C. Mallikarjuna Rao, Lalit Kumar, K. B. Koteshwara

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


Temozolomide is an alkylating agent, used in the treatment of glioblastoma multiforme. The characterization of the pure drug and its expired batch was carried out to evaluate the changes occurred due to degradation of the drug. FT-IR spectrocscopy, DSC analysis and drug content estimation were carried out. The observations indicated the changes in the drug peak and content after expiry period.

Original languageEnglish
Pages (from-to)1841-1845
Number of pages5
JournalAdvanced Science Letters
Issue number3
Publication statusPublished - 01-03-2017

All Science Journal Classification (ASJC) codes

  • Health(social science)
  • Computer Science(all)
  • Education
  • Mathematics(all)
  • Environmental Science(all)
  • Engineering(all)
  • Energy(all)


Dive into the research topics of 'Temozolomide and its stability—a critical factor'. Together they form a unique fingerprint.

Cite this